CVSI
What one share of CV Sciences holds
Pharmaceutical Preparations
CV Sciences, Inc. (“CV Sciences,” the “Company,” “we,” “our” or “us”) is a consumer wellness company specializing in nutraceuticals and plant-based foods. Our hemp extracts and other proven, science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (“B2B”) to business-to-consumer (“B2C”).
CV Sciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.07 |
|---|---|
| Profit | −$0.01 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.00 |
| Cash and investments | $0.00 |
| Debt | $0.00 |
| Book value | $0.01 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $0.21 | −$0.27 | $0.00 | −$0.04 | — | $0.23 |
| 2017 | $0.26 | −$0.06 | $0.01 | $0.04 | — | $0.18 |
| 2018 | $0.42 | $0.09 | $0.01 | $0.10 | — | $0.32 |
| 2019 | $0.55 | −$0.17 | $0.01 | −$0.03 | — | $0.29 |
| 2020 | $0.24 | −$0.22 | $0.01 | −$0.08 | — | $0.11 |
| 2021 | $0.19 | −$0.14 | $0.00 | −$0.07 | — | $0.03 |
| 2022 | $0.12 | −$0.07 | $0.00 | −$0.01 | — | −$0.01 |
| 2023 | $0.10 | $0.02 | $0.00 | $0.01 | — | $0.02 |
| 2024 | $0.09 | −$0.01 | $0.00 | −$0.01 | — | $0.01 |
| 2025 | $0.07 | −$0.01 | $0.00 | −$0.00 | — | $0.01 |